|4Nov 20, 5:08 PM ET

Ludwig Dale L. 4

4 · Actinium Pharmaceuticals, Inc. · Filed Nov 20, 2018

Insider Transaction Report

Form 4
Period: 2018-11-19
Ludwig Dale L.
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2018-11-19$0.45/sh+10,000$4,49910,000 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT